Improving Care for Patients with Hypertrophic Cardiomyopathy

This document is a project report detailing a collaborative initiative between Bristol-Myers Squibb Pharmaceutical Limited and Guy’s and St Thomas’ Hospitals NHS Foundation Trust aimed at enhancing care for patients with Hypertrophic Cardiomyopathy (HCM) and left ventricular outflow tract obstruction (LVOTO). The project focuses on integrating digital solutions and establishing a Clinical Scientist-led LVOTO clinic to improve patient care quality. It outlines the use of Cogstack for efficient identification of patients from unstructured healthcare records and the implementation of Ortus-iHealth to facilitate communication between patients and the ICC service. The report emphasizes the potential benefits for patients, including improved access to evidence-based care and reduced NHS backlog exacerbated by the COVID-19 pandemic. It also discusses the expected outcomes, such as increased outpatient capacity and the sharing of best practices nationally. The project aims to address health inequalities and provide insights for future healthcare improvements.